Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFAF4P4 is a processed pseudogene in the human genome annotated as NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 4. Unlike its functional counterpart NDUFAF4, which encodes a mitochondrial assembly factor involved in respiratory complex I formation and whose mutations cause mitochondrial complex I deficiency[3][14], NDUFAF4P4 itself does not encode a protein and does not contribute to any known biological functions, molecular interactions, or disease processes[7][13][16]. As such, it is not considered a therapeutic target or molecular biomarker, and there are no drugs or safety considerations associated with it. NDUFAF4P4 should not be confused with the functional gene NDUFAF4. The pseudogene status means it has no protein product, no direct biological role, and no actionable disease or drug information. This makes it ineligible for structured information as a conventional target[7][10][13][16].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 4 (NDUFAF4P4).